Imatinib Suspended Phase 2 Trials for Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) Treatment

IndicationsStatusPurposePhase
SuspendedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01222013Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)